about
A review of the proposed role of neutrophils in rodent amebic liver abscess modelsThe Role of Oxygen Sensors, Hydroxylases, and HIF in Cardiac Function and DiseasePharmacology and Clinical Drug Candidates in Redox MedicineReactive oxygen species-activated nanomaterials as theranostic agentsTyrosine modifications in agingReactive Oxygen-Related Diseases: Therapeutic Targets and Emerging Clinical IndicationsLow serum myeloperoxidase in autistic children with gastrointestinal diseaseIncreased atherosclerosis in myeloperoxidase-deficient miceEndothelial transcytosis of myeloperoxidase confers specificity to vascular ECM proteins as targets of tyrosine nitrationThe innate immune response to products of phospholipid peroxidationInhaled matters of the heartHypochlorous acid-induced heme degradation from lactoperoxidase as a novel mechanism of free iron release and tissue injury in inflammatory diseasesImmunolocalization of hypochlorite-induced, catalase-bound free radical formation in mouse hepatocytesMelatonin prevents myeloperoxidase heme destruction and the generation of free iron mediated by self-generated hypochlorous acidGut Microbiota Conversion of Dietary Ellagic Acid into Bioactive Phytoceutical Urolithin A Inhibits Heme PeroxidasesNitric oxide is a physiological substrate for mammalian peroxidasesDevelopment of a new assay for the screening of hypochlorous acid scavengers based on reversed-phase high-performance liquid chromatography.Advancing Urinary Protein Biomarker Discovery by Data-Independent Acquisition on a Quadrupole-Orbitrap Mass SpectrometerMonocytes and neutrophils expressing myeloperoxidase occur in fibrous caps and thrombi in unstable coronary plaques.Clinical significance of the humoral immune response to modified LDL.Comprehensive metabolomics identified lipid peroxidation as a prominent feature in human plasma of patients with coronary heart diseasesAbnormal function of high-density lipoprotein is associated with poor disease control and an altered protein cargo in rheumatoid arthritis.Concurrent evaluation of novel cardiac biomarkers in acute coronary syndrome: myeloperoxidase and soluble CD40 ligand and the risk of recurrent ischaemic events in TACTICS-TIMI 18.Oxidative stress: an essential factor in the pathogenesis of gastrointestinal mucosal diseases.Association of myeloperoxidase with total and cardiovascular mortality in individuals undergoing coronary angiography--the LURIC study.Potential role of tryptophan and chloride in the inhibition of human myeloperoxidase.Activated antigen-presenting cells select and present chemically modified peptides recognized by unique CD4 T cells.Myeloperoxidase levels predicts angiographic severity of coronary artery disease in patients with chronic stable angina.Oxidized phosphatidylcholines: pattern recognition ligands for multiple pathways of the innate immune response.Linoleic acid hydroperoxide reacts with hypochlorous acid, generating peroxyl radical intermediates and singlet molecular oxygenHigh dissociation rate constant of ferrous-dioxy complex linked to the catalase-like activity in lactoperoxidase.Effects of a novel pharmacologic inhibitor of myeloperoxidase in a mouse atherosclerosis model.Postprandial oxidative stress.Delivery of SAR 1118 to the retina via ophthalmic drops and its effectiveness in a rat streptozotocin (STZ) model of diabetic retinopathy (DR)Myeloperoxidase in chronic kidney diseaseEndogenous generation of reactive oxidants and electrophiles and their reactions with DNA and protein.Obesity, aerobic exercise, and vascular disease: the role of oxidant stress.Myeloperoxidase modulates human platelet aggregation via actin cytoskeleton reorganization and store-operated calcium entryIsoprostane generation and function.Nanoimaging in cardiovascular diseases: Current state of the art.
P2860
Q22773404-CFE33E83-A701-42E6-8AD8-6C90125302EFQ26780548-925870D4-300A-4193-A60F-3B67A0049273Q26785525-9648D274-6D8E-499B-855A-3DFAACAFC993Q26865564-4B22A164-5A92-4909-9036-91B8F8C06A5AQ26998450-1201C7DE-0716-40DF-88B9-E1C55BFA81C8Q27024762-FC09F6AC-FD97-426B-B405-E75E57AF3906Q28241398-1A56C29C-E62A-4B93-B202-B65787A5724FQ28350068-D6BE709A-2219-439A-AB0D-8E3170A6C9CBQ28366645-DEACAB07-BCAA-4514-9DDE-547E4E97BA34Q28389385-2AC04441-0104-477C-B6E9-37E8F6554887Q28395876-27EC2495-1045-4316-9432-61853A7E2E16Q28478114-5E754512-0539-469F-8142-769BF5DDF182Q28504837-85386CF1-B9FA-4724-BD7F-30F64C12FC5EQ28545738-1D57161C-E646-41B0-A550-EEF49F258771Q28552586-AE26D3D7-A37A-4E44-91B6-C0EDA300F4D8Q28645799-74856B0D-C377-47FE-823C-D85B0524A3E8Q30847952-E1FD306E-911C-426A-B51B-BCFD331C18C4Q30999645-F351456D-26CF-468B-80A6-97A326B1DC71Q33473042-FB743498-3EE1-4494-B7B6-8B53BA9C001EQ33598770-009A7CF3-2FC5-4C48-AD01-9F6F6E26DE3BQ33633974-A5C452F5-8ABE-49B1-BD6F-30FB14171D7FQ33687843-BC91ADCB-5EE8-4D4C-9255-72849BB53ABDQ33691730-5ACD1591-D998-426F-9BCC-AAE6B01BB36AQ33707944-E57C26C4-8223-44BF-8D19-B44032BA9E92Q33709886-EF8F1DC0-4DBA-4E41-99DC-127A98FF8C0DQ33818264-D9343262-E7C1-462D-84D4-D5A971761039Q33824207-8F1C2BFD-8D09-4709-8ED9-25D4B32C3E05Q34072878-6FEA0D7F-E1EB-48E2-96F0-82B1B5AAFD5EQ34188034-343E567D-EE1E-4762-8D1D-9468F792634CQ34249723-8AC71F7F-BDB2-4701-AA28-07B67C29E2F2Q34333942-ECB0C514-3FB9-4F12-BD54-51C71EA162FFQ34515851-E47DC5B3-1D75-449F-9F25-48D342DD93C1Q34659010-FF863096-E0D4-4B37-A04E-0E6D34659D93Q34735196-2E598587-AA0B-43CC-906D-E557E557DC40Q34747326-9365BFA0-1857-40CA-ABE7-493793EAFD3CQ34835930-6ADB3FE0-780C-46E1-AD5D-3B2A311C9B15Q34844350-6D2F039F-1D87-43B1-B83A-B876A6C60AA0Q35021881-52C6CA7D-E085-4B9B-A5E0-19BD192C422CQ35332267-3DBCDAB5-4A41-4AC0-9F01-0EF7EBCCD16FQ35640852-01E887DB-4530-42B6-A3F2-9E5E8EB494B3
P2860
description
2000 nî lūn-bûn
@nan
2000 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Myeloperoxidase-generated oxidants and atherosclerosis.
@ast
Myeloperoxidase-generated oxidants and atherosclerosis.
@en
Myeloperoxidase-generated oxidants and atherosclerosis.
@nl
type
label
Myeloperoxidase-generated oxidants and atherosclerosis.
@ast
Myeloperoxidase-generated oxidants and atherosclerosis.
@en
Myeloperoxidase-generated oxidants and atherosclerosis.
@nl
prefLabel
Myeloperoxidase-generated oxidants and atherosclerosis.
@ast
Myeloperoxidase-generated oxidants and atherosclerosis.
@en
Myeloperoxidase-generated oxidants and atherosclerosis.
@nl
P2093
P1476
Myeloperoxidase-generated oxidants and atherosclerosis.
@en
P2093
P304
P356
10.1016/S0891-5849(00)00229-X
P577
2000-06-01T00:00:00Z